Dermisonics Competitors
| DMSI Stock | USD 0.00003 0.00 0.00% |
Dermisonics vs North America Correlation
The current Return On Tangible Assets is estimated to decrease to -7.69. The current Return On Capital Employed is estimated to decrease to -0.26. The Dermisonics' current Other Current Assets is estimated to increase to about 491.4 K, while Total Assets are projected to decrease to under 16.4 M.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dermisonics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dermisonics Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Dermisonics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Dermisonics and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Dermisonics does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Dermisonics Stock performing well and Dermisonics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermisonics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IMRSQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SCIE | 0.54 | 0.06 | (0.01) | (0.62) | 0.84 | 1.45 | 8.40 | |||
| BLMS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| STBV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CENBF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AMPE | 139.18 | 65.37 | 0.00 | 22.06 | 0.00 | 1,000.00 | 1,096 | |||
| STAB | 30.94 | 10.43 | 0.15 | (2.46) | 22.33 | 100.00 | 275.00 | |||
| BTTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| UPPR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NAFS | 74,607 | 42,767 | 0.00 | (0.68) | 0.00 | 0.00 | 2,499,957 |
Cross Equities Net Income Analysis
Compare Dermisonics and related stocks such as IMRIS Inc, Spectrascience New, and Bloomios Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMRSQ | 0.0 | (20.9 M) | (27.8 M) | (42 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (27.3 M) | (26 M) |
| STBV | (381.6 K) | (381.6 K) | (381.6 K) | (1 M) | (1.3 M) | (1.2 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.6 M) | (1.7 M) |
Dermisonics and related stocks such as IMRIS Inc, Spectrascience New, and Bloomios Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Dermisonics financial statement analysis. It represents the amount of money remaining after all of Dermisonics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Dermisonics Competitive Analysis
The better you understand Dermisonics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Dermisonics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Dermisonics' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Dermisonics Competition Performance Charts
Five steps to successful analysis of Dermisonics Competition
Dermisonics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Dermisonics in relation to its competition. Dermisonics' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Dermisonics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Dermisonics' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Dermisonics, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Dermisonics position
In addition to having Dermisonics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Equity ETFs Thematic Idea Now
Broad Equity ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 548 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Dermisonics Correlation with its peers. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is there potential for Medical Devices market expansion? Will Dermisonics introduce new products? Factors like these will boost the valuation of Dermisonics. Projected growth potential of Dermisonics fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Dermisonics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Dermisonics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Dermisonics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Dermisonics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Dermisonics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dermisonics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Dermisonics' market price signifies the transaction level at which participants voluntarily complete trades.